Orgenesis Corporation (ORGS): Growth-Adjusted Payback Ratio

Corporate company logo of Orgenesis Corporation (ORGS)

Orgenesis Inc. (ORGS) is developing OCGM mobile laboratories and gene therapy software by implementing IT innovations. The P/E ratio relative to earnings dynamics reflects market expectations, where the value 0.00 represents the current metric. Orgenesis Inc. (ORGS) is scaling cellular medicine in partnership with clinics to develop a decentralized production system, which will significantly optimize biologics logistics by 2026.

Orgenesis Inc. (ORGS) PEG Multiple: for the period 07/04/2022 - 10/26/2024
Manufactured products of Orgenesis Corp

By developing a decentralized production platform for gene therapies and medical IT solutions, Orgenesis Inc. demonstrates specific profit scaling dynamics. Analyzing the PEG ratio, an investor assesses the market value of the stock relative to EPS growth rates: a value below one indicates that the asset is undervalued, confirming the company's high investment attractiveness at the current risk premium level.

Competing companies

VEEV - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Doximity Corp DOCS|Growth-Adjusted Payback Ratio HQY|Waystar Holding Corp. - PEG Multiple|Price to Net Income Growth Ratio corvel.com (CRVL)|PRVA: PEG Multiple|Price to Earnings Adjusted for Growth Rate Huron Consulting Group Inc. (HURN)|Price/Earnings to Growth Ratio Certara Corp|Growth-Adjusted P/E Ratio OMCL (Omnicell Health)|PEG Multiple GDRX|SDGR - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Phreesia PHR|Growth-Adjusted Market Cap to Net Income Omada Health, Inc. (OMDA)|Evolent - PEG Multiple|Growth-Adjusted Market Cap to Net Income HealthStream Learning HSTM|Definitive Healthcare (DH) - Price/Earnings to Growth Ratio|CCSI - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple AGL|ABSI: Growth-Adjusted Payback Ratio|PEG Multiple SY|Growth-Adjusted Market Cap to Net Income National Research Corp.|Price/Earnings to Growth Ratio Spok Holdings, Inc. SPOK|OPRX: Growth-Adjusted P/E Ratio|TruBridge - PEG Multiple|Simulations Plus Inc (SLP) - Price/Earnings to Growth Multiple|SOPH (sophiagenetics.com) - Price/Earnings to Growth Multiple|HCAT - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio CareCloud Inc.|Price to Earnings Adjusted for Growth Rate researchsolutions.com RSSS|Price/Earnings to Growth Ratio DLH Holdings Corp. (DLHC)|ONMD (onemednet.com) - Growth-Adjusted Payback Ratio|PEG Multiple SCNX (Scienture Holdings Inc.)|Price to Net Income Growth Ratio Healthcare Triangle Corporation|ISPC - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income Bullfrog AI Holdings BFRG|WORX: PEG Multiple|MSPR - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple ICCT|MEDS (TRxADE Health Corp) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple RCM (R1 RCM Inc.)|SHCR (sharecare.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Streamline Health STRM|SYRA - Price/Earnings to Growth Multiple|ApolloMed - PEG Multiple|Price to Earnings Adjusted for Growth Rate Model N Corporation|NXGN: PEG Multiple